Managed by Maven and delivered by the British Business Bank, Scottish Enterprise, and SIS Ventures, the Investment Fund for Scotland backs growing businesses in the region.
The seed round was led by Eos Advisory alongside regional public and private backers.
"Robot-assisted surgery has become increasingly popular in recent years and is now widely used in various surgical procedures including urology, gynaecology, and colorectal. We have pilot programmes running with healthcare and medical device groups worldwide, including in the United States, and we now look forward to the commercialisation phase with the support of our new investors."
The funding will support the Edinburgh biotechnology firm in bringing its FDA-approved medical device to international markets.
"Early diagnosis and treatment of tooth decay is essential, allowing patients to reverse the damage to their teeth before it is too late. This investment will enable us to launch our innovative product to global markets – first in the US and eventually in the UK – leading to faster diagnoses and early intervention treatments."